Zylox-Tonbridge Proposes 2024 Final Dividend Distribution

Zylox-Tonbridge Medical Technology Co., Ltd. Class H ( (HK:2190) ) has issued an update.

Zylox-Tonbridge Medical Technology Co., Ltd. has announced a proposed final dividend for the year ending December 31, 2024, amounting to RMB0.1 per share, totaling approximately RMB32,472,500.10. This proposal is subject to approval at the company’s annual general meeting in May 2025, with dividends to be paid in Renminbi for domestic and certain H Shares, and in Hong Kong dollars for others, based on the exchange rate set by the People’s Bank of China. If approved, the dividend will be distributed by June 27, 2025, with specific eligibility requirements for shareholders.

More about Zylox-Tonbridge Medical Technology Co., Ltd. Class H

Zylox-Tonbridge Medical Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the medical technology industry. The company focuses on developing and distributing medical devices and technologies, with a market presence that includes both domestic and international stakeholders.

YTD Price Performance: 63.08%

Average Trading Volume: 141

Technical Sentiment Signal: Sell

Current Market Cap: €717.7M

For detailed information about 2190 stock, go to TipRanks’ Stock Analysis page.